RIL
KRYS icon

Rothschild Investment LLC’s Krystal Biotech KRYS Stock Holding History

Rothschild Investment LLC’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.3K Buy
33
+5
+18% +$1.49K ﹤0.01% 1769
2026
Q1 		$7.23K Hold
28
– – ﹤0.01% 1864
2025
Q4 		$6.9K Buy
28
+2
+8% +$421 ﹤0.01% 1729
2025
Q3 		$4.59K Sell
26
-13
-33% -$1.95K ﹤0.01% 1746
2025
Q2 		$5.36K Sell
39
-7
-15% -$1.03K ﹤0.01% 1483
2025
Q1 		$8.29K Buy
46
+29
+171% +$4.88K ﹤0.01% 1223
2024
Q4 		$2.66K Sell
17
-8
-32% -$1.42K ﹤0.01% 1632
2024
Q3 		$4.55K Buy
25
+17
+213% +$3.28K ﹤0.01% 1330
2024
Q2 		$1.47K Buy
8
+6
+300% +$1.01K ﹤0.01% 1492
2024
Q1 		$356 Buy
+2
New +$278 ﹤0.01% 1484

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Rothschild Investment LLC's KRYS Position: Q2 2026 in Review

Rothschild Investment LLC increased its Krystal Biotech (KRYS) stake by 18% in Q2 2026, buying an estimated $1.49K and bringing the position to 33 shares worth $12.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1769.

Rothschild Investment LLC first reported a position in KRYS in Q1 2024 and has held it in 10 quarters since. 423 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Rothschild Investment LLC held 33 shares of Krystal Biotech worth $12.3K as of Q2 2026.
  • Rothschild Investment LLC bought 5 Krystal Biotech shares in Q2 2026, an estimated $1.49K.
  • Krystal Biotech made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #1769 holding.
  • Rothschild Investment LLC first reported a position in Krystal Biotech in Q1 2024 and has held it in 10 quarters since.
  • 423 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.